Axonics sacral neuromodulation system for treating refractory overactive bladder (HTG554)Product type:GuidanceProgramme:HealthTech guidancePublished: 3 September 2020
Bedwetting in under 19s (CG111)Product type:GuidanceProgramme:Clinical guidelinePublished: 27 October 2010
High intensity focused electromagnetic (HIFEM) energy to target the pelvic floor musclesStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Male sling for stress urinary incontinenceStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Mirabegron for treating symptoms of overactive bladder (TA290)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 June 2013
MT547 QuickChange Incontinence Wrap for urinary incontinence in men (MIB237)Status:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC
Pelvic floor dysfunction: prevention and non-surgical management (NG210)Product type:GuidanceProgramme:NICE guidelinePublished: 9 December 2021
Single-incision short sling mesh insertion for stress urinary incontinence in womenStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisationStatus:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)Status:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)Status:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC
Urinary incontinence and pelvic organ prolapse in women: management (NG123)Product type:GuidanceProgramme:NICE guidelineLast updated: 24 June 2019Published: 2 April 2019
Urinary incontinence in neurological disease: assessment and management (CG148)Product type:GuidanceProgramme:Clinical guidelineLast updated: 2 October 2023Published: 8 August 2012
Urolon, (MT821)Status:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC
Vibegron for treating symptoms of overactive bladder syndrome (TA999)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 4 September 2024